Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

NCT06177691 is registered in ClinicalTrials.gov with Jaeb Center for Health Research as lead sponsor.

NCT NCT06177691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06177691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study
Lead sponsor
Jaeb Center for Health Research
Phase
Observational
Overall status
Completed
Start date
May 7, 2021
Completion date
March 31, 2026
Enrollment
77 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

type1 diabetes